Blazar BR - Search Results

1

Anti-CD3 + IL-2-stimulated murine killer cells. In vitro generation and in vivo antitumor activity.

Anderson PM, Blazar BR, Bach FH, Ochoa AC. Anderson PM, et al. Among authors: blazar br. J Immunol. 1989 Feb 15;142(4):1383-94. J Immunol. 1989. PMID: 2521662

2

Anti-CD3 immunotoxin prevents low-dose STZ/interferon-induced autoimmune diabetes in mouse.

Vallera DA, Carroll SF, Brief S, Blazar BR. Vallera DA, et al. Among authors: blazar br. Diabetes. 1992 Apr;41(4):457-64. doi: 10.2337/diab.41.4.457. Diabetes. 1992. PMID: 1376702

3

T cell depletion with anti-CD5 immunotoxin in histocompatible bone marrow transplantation. The correlation between residual CD5 negative T cells and subsequent graft-versus-host disease.

Filipovich AH, Vallera D, McGlave P, Polich D, Gajl-Peczalska K, Haake R, Lasky L, Blazar B, Ramsay NK, Kersey J, et al. Filipovich AH, et al. Transplantation. 1990 Sep;50(3):410-5. doi: 10.1097/00007890-199009000-00011. Transplantation. 1990. PMID: 1698319

4

Importance in timing of cyclophosphamide on the enhancement of interleukin-2-induced cytolysis.

Katsanis E, Bausero MA, Ochoa AC, Loeffler CM, Blazar BR, Leonard AS, Anderson PM. Katsanis E, et al. Among authors: blazar br. Cancer Immunol Immunother. 1991;34(2):74-8. doi: 10.1007/BF01741339. Cancer Immunol Immunother. 1991. PMID: 1760819 Free PMC article.

5

In vivo administration of anti-CD3 monoclonal antibodies or immunotoxins in murine recipients of allogeneic T cell-depleted marrow for the promotion of engraftment.

Blazar BR, Hirsch R, Gress RE, Carroll SF, Vallera DA. Blazar BR, et al. J Immunol. 1991 Sep 1;147(5):1492-503. J Immunol. 1991. PMID: 1831826

6

Toxicity and efficacy of anti-T-cell ricin toxin A chain immunotoxins in a murine model of established graft-versus-host disease induced across the major histocompatibility barrier.

Vallera DA, Carroll SF, Snover DC, Carlson GJ, Blazar BR. Vallera DA, et al. Among authors: blazar br. Blood. 1991 Jan 1;77(1):182-94. Blood. 1991. PMID: 1984794 Free article.

7

Absence of a facilitory role for NK 1.1-positive donor cells in engraftment across a major histocompatibility barrier in mice.

Blazar BR, Soderling CC, Koo GC, Vallera DA. Blazar BR, et al. Transplantation. 1988 May;45(5):876-83. doi: 10.1097/00007890-198805000-00007. Transplantation. 1988. PMID: 2897141

8

In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice.

Blazar BR, Taylor PA, Linsley PS, Vallera DA. Blazar BR, et al. Blood. 1994 Jun 15;83(12):3815-25. Blood. 1994. PMID: 7515723 Free article.

9

FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation.

Blazar BR, Taylor PA, Fitzsimmons WE, Vallera DA. Blazar BR, et al. J Immunol. 1994 Aug 15;153(4):1836-46. J Immunol. 1994. PMID: 7519216

10

B7-1 expression decreases tumorigenicity and induces partial systemic immunity to murine neuroblastoma deficient in major histocompatibility complex and costimulatory molecules.

Katsanis E, Xu Z, Bausero MA, Dancisak BB, Gorden KB, Davis G, Gray GS, Orchard PJ, Blazar BR. Katsanis E, et al. Among authors: blazar br. Cancer Gene Ther. 1995 Mar;2(1):39-46. Cancer Gene Ther. 1995. PMID: 7542553

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

904 results

Search Page

Filters